DENISHA BLACHER: Open Payments
NPI 1669129631 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$836 in 37 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $155 · 2025 $836
Food & beverage: $836
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $186 |
| Alexion Pharmaceuticals, Inc. | 4 | $119 |
| TG Therapeutics, Inc. | 4 | $113 |
| Amgen Inc. | 5 | $87 |
| C2N Diagnostics, LLC | 3 | $77 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| ARGENX US, INC. | 2 | $39 |
| Biogen, Inc. | 1 | $28 |
| SK Life Science, Inc. | 1 | $26 |
| Lundbeck LLC | 1 | $25 |
Products named: ULTOMIRIS, BRIUMVI, Rystiggo, UPLIZNA, PRECIVITYAD2, Symbravo, Nayzilam, Fintepla.
Industry payments across TN — which companies pay providers there.
